SOLARA ACTIVE PHARMA SCIENCES LTD.
Market Cap.(`)
|
1846.79 Cr.
|
P/BV
|
1.23
|
Book Value (`)
|
416.48
|
52 Week High/Low ( ` )
|
606/286
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
Book Closure
|
15/09/2023
|
EPS (`)
|
0.00
|
Div Yield (%)
|
0.00
|
(` in Crs.)
You can view the
Consolidated
Income Statement
for the last 5 years.
Months | 12 | 12 | 12 | 12 | 14 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
| | | | | |
INCOME | | | | | |
Revenue From Operations [Net] | 1379.19 | 1230.55 | 1575.73 | 1267.64 | 1322.08 |
Other Operating Revenues | 64.62 | 37.79 | 41.15 | 54.11 | 64.59 |
Total Operating Revenues | 1443.81 | 1268.34 | 1616.88 | 1321.75 | 1386.68 |
| | | | | |
Other Income | 22.55 | 20.02 | 28.77 | 27.52 | 12.38 |
Total Revenue | 1466.36 | 1288.36 | 1645.65 | 1349.27 | 1399.06 |
| | | | | |
EXPENSES | | | | | |
Cost Of Materials Consumed | 773.90 | 858.86 | 683.77 | 623.36 | 729.54 |
Purchase Of Stock-In Trade | 7.88 | 53.78 | 42.80 | 29.67 | 9.08 |
Changes In Inventories Of FG,WIP And Stock-In Trade | 7.05 | -258.75 | -2.15 | -54.16 | -33.79 |
Employee Benefit Expenses | 228.63 | 236.34 | 229.37 | 204.13 | 185.81 |
Finance Costs | 90.06 | 75.28 | 84.48 | 77.89 | 82.42 |
Depreciation And Amortisation Expenses | 111.19 | 112.32 | 108.66 | 94.16 | 83.09 |
Other Expenses | 292.47 | 298.14 | 277.22 | 259.31 | 275.23 |
Total Expenses | 1511.18 | 1375.97 | 1424.15 | 1234.36 | 1331.37 |
| | | | | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | -44.82 | -87.61 | 221.50 | 114.91 | 67.69 |
| | | | | |
Exceptional Items | 0.00 | -3.49 | 0.00 | 0.00 | 0.00 |
Profit/Loss Before Tax | -44.82 | -91.10 | 221.50 | 114.91 | 67.69 |
| | | | | |
Tax Expenses-Continued Operations | | | | | |
Current Tax | -0.09 | 0.17 | 38.80 | 21.22 | 15.97 |
Deferred Tax | -22.48 | -32.98 | -38.65 | -20.69 | -13.95 |
Tax For Earlier Years | 0.00 | 0.00 | 0.00 | -0.14 | -1.43 |
Total Tax Expenses | -22.57 | -32.81 | 0.15 | 0.39 | 0.59 |
Profit/Loss After Tax And Before ExtraOrdinary Items | -22.25 | -58.29 | 221.35 | 114.52 | 67.10 |
| | | | | |
Profit/Loss From Continuing Operations | -22.25 | -58.29 | 221.35 | 114.52 | 67.10 |
| | | | | |
Profit/Loss From Discontinuing Operations | 0.00 | 0.00 | 0.00 | 0.00 | -9.92 |
Total Tax Expenses Discontinuing Operations | 0.00 | 0.00 | 0.00 | 0.00 | -2.24 |
Net Profit/Loss From Discontinuing Operations | 0.00 | 0.00 | 0.00 | 0.00 | -7.68 |
Profit/Loss For The Period | -22.25 | -58.29 | 221.35 | 114.52 | 59.43 |
| | | | | |
Minority Interest | 0.07 | 0.14 | 0.05 | 0.09 | 0.10 |
Consolidated Profit/Loss After MI And Associates | -22.18 | -58.15 | 221.40 | 114.61 | 59.53 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
EARNINGS PER SHARE | | | | | |
Basic EPS (Rs.) | -6.16 | -16.18 | 69.00 | 44.29 | 21.77 |
Diluted EPS (Rs.) | -6.16 | -16.18 | 64.53 | 42.82 | 21.73 |
| | | | | |
DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
Equity Share Dividend | 0.00 | 10.78 | 19.72 | 15.63 | 0.00 |